JB Pharma cuts fee outfits top-promoting coronary heart failure drug Azmarda via way of means of 50%. Health December 6, 2022 JB Pharma on Monday introduced a 50% fee reduction for its heart failure drug Azmarda, which is a sacubitril-valsartan combination,…